Infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease (COVID-19), has spread widely around the globe. Significant inter-individual differences have been observed during the course of the infection, which suggests that genetic susceptibility may be a contributing factor. CC chemokine receptor 5 (CCR5), which acts as a co-receptor for the entry of HIV-1 into cells, is promising candidate whose can have an influence on SARS-CoV-2 infection. A genetic mutation known as CCR5Delta32, consisting of a 32-nucleotide deletion, encodes a truncated protein that protects homozygous carriers of the deletion from HIV-1 infection. Similarly, inhibition of CCR5 seems to be protective against COVID-19. In our study, we successfully genotyped 416 first-wave SARS-CoV-2-positive infection survivors (164 asymptomatic and 252 symptomatic) for CCR5?32, comparing them with a population based sample of 2,404 subjects. We found the highest number (P=0.03) of CCR5Delta32 carriers in SARS-CoV-2-positive/COVID-19-asympto-matic subjects (23.8 %) and the lowest number in SARS-CoV-2-positive/COVID-19-symptomatic patients (16.7 %), with frequency in the control population in the middle (21.0 %). We conclude that the CCR5?32 I/D polymorphism may have the potential to predict the severity of SARS-CoV-2 infection.

Experimental Medicine Centre Institute for Clinical and Experimental Medicine Prague 4 Czech Republic

Zobrazit více v PubMed

BELLONE M, CALVISI SL. ACE polymorphism and COVID-19-related mortality in Europe. Mol Med (Berl) 2020;98:1505–1509. doi: 10.1007/s00109-020-01981-0. PubMed DOI PMC

BEREKAA MM. Insights into the COVID-19 pandemic: Origin, pathogenesis, diagnosis, and therapeutic interventions. Front Biosci (Elite Ed) 2021;13:117–139. doi: 10.2741/874. PubMed DOI

CASANOVA JL. Human genetic basis of interindividual variability in the course of infection. Proc Natl Acad Sci U S A. 2015;112:E7118–E7127. doi: 10.1073/pnas.1521644112. PubMed DOI PMC

CÍFKOVÁ R, SKODOVÁ Z, BRUTHANS J, ADÁMKOVÁ V, JOZÍFOVÁ M, GALOVCOVÁ M, WOHLFAHRT P, KRAJCOVIECHOVÁ A, POLEDNE R, STÁVEK P, LÁNSKÁ V. Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA. Atherosclerosis. 2010;211:676–681. doi: 10.1016/j.atherosclerosis.2010.04.007. PubMed DOI

DRÁBEK J, PETREK M. 32 bp deletion in CCR-5 gene and human immunodeficiency virus epidemic in the Czech Republic. Acta Virol. 1998;42:121–122. PubMed

ELHABYAN A, ELYAACOUB S, SANAD E, ABUKHADRA A, ELHABYAN A, DINU V. The role of host genetics in susceptibility to severe viral infections in humans and insights into host genetics of severe COVID-19: A systematic review. Virus Res. 2020;289:198163. doi: 10.1016/j.virusres.2020.198163. PubMed DOI PMC

ELLWANGER JH, KULMANN-LEAL B, KAMINSKI VL, RODRIGUES AG, BRAGATTE MAS, CHIES JAB. Beyond HIV infection: Neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases. Virus Res. 2020;286:198040. doi: 10.1016/j.virusres.2020.198040. PubMed DOI PMC

HIPPISLEY-COX J, YOUNG D, COUPLAND C, CHANNON KM, TAN PS, HARRISON DA, ROWAN K, AVEYARD P, PAVORD ID, WATKINSON PJ. Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: Cohort study including 8. million people. Heart. 2020;106:1503–1511. doi: 10.1136/heartjnl-2020-317393. PubMed DOI PMC

HUBACEK JA, PITHA J, ADAMKOVA V, LANSKA V, POLEDNE R. A common variant in the FTO gene is associated with body mass index in males and postmenopausal females but not in premenopausal females. Czech post-MONICA and 3PMFs studies. Clin Chem Lab Med. 2009;47:387–390. doi: 10.1515/CCLM.2009.109. PubMed DOI

HÜTTER G, BLÜTHGEN C, ELVERS-HORNUNG S, KLÜTER H, BUGERT P. Distribution of the CCR5-delta32 deletion in Southwest Germany. Anthropol Anz. 2015;72:303–309. doi: 10.1127/anthranz/2015/0479. PubMed DOI

KLIGER Y, LEVANON EY. Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy. BMC Microbiol. 2003;3:20. doi: 10.1186/1471-2180-3-20. PubMed DOI PMC

LIBERT F, COCHAUX P, BECKMAN G, SAMSON M, AKSENOVA M, CAO A, CZEIZEL A, CLAUSTRES M, De la RÚA C, FERRARI M, FERREC C, GLOVER G, GRINDE B, GÜRAN S, KUCINSKAS V, LAVINHA J, MERCIER B, OGUR G, PELTONEN L, ROSATELLI C, ET AL. The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe. Hum Mol Genet. 1998;7:399–406. doi: 10.1093/hmg/7.3.399. PubMed DOI

LIU R, PAXTON WA, CHOE S, CERADINI D, MARTIN SR, HORUK R, MacDONALD ME, STUHLMANN H, KOUP RA, LANDAU NR. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 1996;86:367–377. doi: 10.1016/S0092-8674(00)80110-5. PubMed DOI

MEHLOTRA RK. Chemokine receptor gene polymorphisms and COVID-19: Could knowledge gained from HIV/AIDS be important? Infect Genet Evol. 2020;85:104512. doi: 10.1016/j.meegid.2020.104512. PubMed DOI PMC

MEHTA P, McAULEY DF, BROWN M, SANCHEZ E, TATTERSALL RS, MANSON JJ HLH ACROSS SPECIALITY COLLABORATION UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–1034. doi: 10.1016/S0140-6736(20)30628-0. PubMed DOI PMC

OVSYANNIKOVA IG, HARALAMBIEVA IH, CROOKE SN, POLAND GA, KENNEDY RB. The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity. Immunol Rev. 2020;296:205–219. doi: 10.1111/imr.12897. PubMed DOI PMC

PACES J, STRIZOVA Z, SMRZ D, CERNY J. COVID-19 and the immune system. Physiol Res. 2020;69:379–388. doi: 10.33549/physiolres.934492. PubMed DOI PMC

PATTERSON BK, SEETHAMRAJU H, DHODY K, CORLEY MJ, KAZEMPOUR K, LALEZARI J, PANG APS, SUGAI C, MAHYARI E, FRANCISCO EB, ET AL. CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14. Int J Infect Dis. 103:25–32. doi: 10.1016/j.ijid.2020.10.101. PubMed DOI PMC

RAY PR, WANGZHOU A, GHNEIM N, YOUSUF MS, PAIGE C, TAVARES-FERREIRA D, MWIRIGI JM, SHIERS S, SANKARANARAYANAN I, McFARLAND AJ, NEERUKONDA SV, DAVIDSON S, DUSSOR G, BURTON MD, PRICE TJ. A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction. Brain Behav Immun. 2020;89:559–568. doi: 10.1016/j.bbi.2020.05.078. PubMed DOI PMC

SEVERE COVID-19 GWAS GROUP. ELLINGHAUS D, DEGENHARDT F, BUJANDA L, BUTI M, ALBILLOS A, INVERNIZZI P, FERNÁNDEZ J, PRATI D, BASELLI G, ET AL. Genomewide association study of severe covid-19 with respiratory failure. N Engl J Med. 2020;383:1522–1534. doi: 10.1056/NEJMoa2020283. PubMed DOI PMC

VAŠKŮ A. Covid-19 infection and the host genetic predisposition: Does it exist? Physiol Res. 2020;69:511–514. doi: 10.33549/physiolres.934504. PubMed DOI PMC

VENKATESAN S, PETROVIC A, Van RYK DI, LOCATI M, WEISSMAN D, MURPHY PM. Reduced cell surface expression of CCR5 in CCR5Delta 32 heterozygotes is mediated by gene dosage, rather than by receptor sequestration. J Biol Chem. 2002;277:2287–2301. doi: 10.1074/jbc.M108321200. PubMed DOI

WU L, PAXTON WA, KASSAM N, RUFFING N, ROTTMAN JB, SULLIVAN N, CHOE H, SODROSKI J, NEWMAN W, KOUP RA, MACKAY CR. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med. 1997;185:1681–1691. doi: 10.1084/jem.185.9.1681. PubMed DOI PMC

YAMAMOTO N, ARIUMI Y, NISHIDA N, YAMAMOTO R, BAUER G, GOJOBORI T, SHIMOTOHNO K, MIZOKAMI M. SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype. Gene. 2020;758:144944. doi: 10.1016/j.gene.2020.144944. PubMed DOI PMC

ZWOLIŃSKA K, KNYSZ B, RYBKA K, PAZGAN-SIMON M, GĄSIOROWSKI J, SOBCZYŃSKI M, GŁADYSZ A, PIASECKI E. Protective effect of CCR5-Δ32 against HIV infection by the heterosexual mode of transmission in a Polish population. AIDS Res Hum Retroviruses. 2013;29:54–60. doi: 10.1089/aid.2011.0362. PubMed DOI

ABCA3 and LZTFL1 Polymorphisms and Risk of COVID-19 in the Czech Population

A haemochromatosis-causing HFE mutation is associated with SARS-CoV-2 susceptibility in the Czech population

SARS-CoV-2 viral load assessment in lung transplantation

Effects of selected inherited factors on susceptibility to SARS-CoV-2 infection and COVID-19 progression

Could the CCR5-Delta32 mutation be protective in SARS-CoV-2 infection?

ACE I/D polymorphism in Czech first-wave SARS-CoV-2-positive survivors

Apolipoprotein E4 Allele in Subjects with COVID-19